7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Liminal BioSciences Inc
(NASDAQ:LMNL) 

LMNL stock logo

Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on discovery, development, and commercialization of novel small molecule drug candidates for the treatment of patients suffering from respiratory fibrotic diseases and other fibrotic or inflammatory diseases that have high...

Founded: 1994
Full Time Employees: 300
CEO: Kenneth Harry Galbraith  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Liminal BioSciences Days Payable Outstanding ttm (DPO)
202110 202111 202112 202201 202202 202203 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0796.541,593.082,389.623,186.163,982.74,779.245,575.77
Liminal BioSciences Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0196.26392.51588.77785.03981.281,177.541,373.79
Liminal BioSciences Days Inventory Outstanding ttm (DIO)
202110 202111 202112 202201 202202 202203 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0276.16552.33828.491,104.661,380.821,656.981,933.15
Liminal BioSciences Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -11.64-9.97-8.31-6.65-4.99-3.32-1.660
Liminal BioSciences Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -11.63-9.97-8.31-6.65-4.98-3.32-1.660
Liminal BioSciences Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.242.483.724.966.27.448.68
Liminal BioSciences P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 099.81199.61299.42399.22499.03598.84698.64
Liminal BioSciences (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -20.25-2.8114.6332.0749.566.9484.38101.82
Liminal BioSciences P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.831.662.493.324.154.995.82
No extra charts and metrics for this ticker.